Evidence map›Paper›PMID 25575540›Full record

ArticleBlood2015

Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies.

Christian A Di Buduo, Lindsay S Wray, Lorenzo Tozzi, Alessandro Malara, Ying Chen, Chiara E Ghezzi, Daniel Smoot, Carla Sfara, Antonella Antonelli, Elise Spedden and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 161 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Production of plateletsHaematologica · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Inside-to-outside and back to the future of megakaryopoiesis.Research and practice in thrombosis and haemostasis · 2023
    Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Christian A Di BuduoDepartment of Molecular Medicine, University of Pavia, Pavia, Italy; Biotechnology Research Laboratories, Istituto di Ricovero e Cura a Carattere Scientifico San Matteo Foundation, Pavia, Italy;
Lindsay S WrayDepartment of Molecular Medicine, University of Pavia, Pavia, Italy; Biotechnology Research Laboratories, Istituto di Ricovero e Cura a Carattere Scientifico San Matteo Foundation, Pavia, Italy; Department of Biomedical Engineering, Tufts University, Medford, MA;
Lorenzo TozziDepartment of Molecular Medicine, University of Pavia, Pavia, Italy; Biotechnology Research Laboratories, Istituto di Ricovero e Cura a Carattere Scientifico San Matteo Foundation, Pavia, Italy; Department of Biomedical Engineering, Tufts University, Medford, MA;
Alessandro MalaraDepartment of Molecular Medicine, University of Pavia, Pavia, Italy; Biotechnology Research Laboratories, Istituto di Ricovero e Cura a Carattere Scientifico San Matteo Foundation, Pavia, Italy;
Ying ChenDepartment of Biomedical Engineering, Tufts University, Medford, MA;
Chiara E GhezziDepartment of Biomedical Engineering, Tufts University, Medford, MA;
Daniel SmootDepartment of Biomedical Engineering, Tufts University, Medford, MA;
Carla SfaraDepartment of Biomolecular Sciences, Biochemistry and Molecular Biology Section, University of Urbino "Carlo Bo," Urbino, Italy;
Antonella AntonelliDepartment of Biomolecular Sciences, Biochemistry and Molecular Biology Section, University of Urbino "Carlo Bo," Urbino, Italy;
Elise SpeddenDepartment of Physics, Tufts University, Medford, MA;
Giovanna BruniDepartment of Chemistry, Physical Chemistry Section, University of Pavia, Pavia, Italy;
Cristian StaiiDepartment of Physics, Tufts University, Medford, MA;
Luigi De MarcoDepartment of Translational Research, Stem Cells Unit, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico, Aviano, Italy; and Department of Molecular and Experimental Research, The Scripps Research Institute, La Jolla, CA.
Mauro MagnaniDepartment of Biomolecular Sciences, Biochemistry and Molecular Biology Section, University of Urbino "Carlo Bo," Urbino, Italy;
David L KaplanDepartment of Biomedical Engineering, Tufts University, Medford, MA;
Alessandra BalduiniDepartment of Molecular Medicine, University of Pavia, Pavia, Italy; Biotechnology Research Laboratories, Istituto di Ricovero e Cura a Carattere Scientifico San Matteo Foundation, Pavia, Italy; Department of Biomedical Engineering, Tufts University, Medford, MA;
Tufts University · USIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Pavia · ITUniversity of Urbino · ITCentro di Riferimento Oncologico · IT

Funding

In vitro bioreactor system for platelet formationR01EB016041 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI BALDUINI, ALESSANDRA, KAPLAN, DAVID L. · 2012 to 2020
$2.7M
NIBIB NIH HHS EB016041-01NIBIB NIH HHS R01 EB016041
6 · The paper itself

Abstract

We present a programmable bioengineered 3-dimensional silk-based bone marrow niche tissue system that successfully mimics the physiology of human bone marrow environment allowing us to manufacture functional human platelets ex vivo. Using stem/progenitor cells, megakaryocyte function and platelet generation were recorded in response to variations in extracellular matrix components, surface topography, stiffness, coculture with endothelial cells, and shear forces. Millions of human platelets were produced and showed to be functional based on multiple activation tests. Using adult hematopoietic progenitor cells our system demonstrated the ability to reproduce key steps of thrombopoiesis, including alterations observed in diseased states. A critical feature of the system is the use of natural silk protein biomaterial allowing us to leverage its biocompatibility, nonthrombogenic features, programmable mechanical properties, and surface binding of cytokines, extracellular matrix components, and endothelial-derived proteins. This in turn offers new opportunities for the study of blood component production ex vivo and provides a superior tissue system for the study of pathologic mechanisms of human platelet production.

Indexed as

AdultAnimalsBlood PlateletsBombyxBone Marrow CellsCells, CulturedCoculture TechniquesEndothelium, VascularExtracellular MatrixFlow CytometryHematopoietic Stem CellsHumansMegakaryocytesPrimary MyelofibrosisSilkThrombopoiesisSilk

Identifiers

PMID25575540
PMCPMC4383799
OpenAlexW2079552505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.